BFG
CVS icon

Bleakley Financial Group’s CVS Health CVS Stock Holding History

Bleakley Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
101,852
+61,431
+152% +$5.48M 0.13% 121
2026
Q1 		$2.9M Buy
40,421
+1,203
+3% +$92.7K 0.05% 308
2025
Q4 		$3.11M Sell
39,218
-25,268
-39% -$1.99M 0.05% 273
2025
Q3 		$4.86M Buy
64,486
+37,721
+141% +$2.59M 0.11% 159
2025
Q2 		$1.85M Sell
26,765
-23,150
-46% -$1.52M 0.05% 285
2025
Q1 		$3.38M Buy
49,915
+29,975
+150% +$1.79M 0.11% 172
2024
Q4 		$895K Sell
19,940
-4,410
-18% -$247K 0.03% 448
2024
Q3 		$1.53M Sell
24,350
-996
-4% -$58.1K 0.05% 306
2024
Q2 		$1.5M Sell
25,346
-6,196
-20% -$388K 0.04% 331
2024
Q1 		$2.52M Sell
31,542
-893
-3% -$68.2K 0.07% 250
2023
Q4 		$2.56M Buy
32,435
+2,740
+9% +$195K 0.08% 232
2023
Q3 		$2.07M Sell
29,695
-2,576
-8% -$183K 0.07% 254
2023
Q2 		$2.23M Buy
32,271
+2,930
+10% +$208K 0.07% 248
2023
Q1 		$2.18M Sell
29,341
-26,642
-48% -$2.23M 0.07% 236
2022
Q4 		$5.22M Buy
+55,983
New +$5.4M 0.19% 107

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bleakley Financial Group's CVS Position: Q2 2026 in Review

Bleakley Financial Group increased its CVS Health (CVS) stake by 152% in Q2 2026, buying an estimated $5.48M and bringing the position to 101,852 shares worth $10.5M. The position accounts for 0.13% of the portfolio, ranked #121.

Bleakley Financial Group first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bleakley Financial Group held 101,852 shares of CVS Health worth $10.5M as of Q2 2026.
  • Bleakley Financial Group bought 61,431 CVS Health shares in Q2 2026, an estimated $5.48M.
  • CVS Health made up 0.13% of Bleakley Financial Group's portfolio in Q2 2026, its #121 holding.
  • Bleakley Financial Group first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.